ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: PO0247

Inhibition of Acetyl-CoA Carboxylase in Acutely Injured Tubular Cells Exacerbates DNA Damage and Mitochondria Fission in Diabetic Nephropathy

Session Information

  • AKI Mechanisms - 3
    October 22, 2020 | Location: On-Demand
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms


  • Liu, Xiangchun, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Li, Jiahua, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Cheng, Shun-Yang, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Li, Guixia, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Bonventre, Joseph V., Brigham and Women's Hospital, Boston, Massachusetts, United States

Both diabetes and acute tubular injury (ATI) alter lipid metabolism of proximal tubules. Inhibiting lipogenesis causes G2/M cell cycle arrest, which can cause maladaptive tubular repair. Acetyl-CoA carboxylase (ACC) stimulates lipogenesis and inhibits fatty acid oxidation (FAO). Phosphorylation (p-ACC) inhibits ACC, which inhibits lipogenesis and promotes FAO. We hypothesized that p-ACC exacerbates DNA damage and mitochondria dysfunction in diabetic nephropathy (DN) after ATI.


Human DN samples were co-stained for p-ACC, KIM-1, and a-SMA. ATI was introduced by a single diphtheria toxin (DT) injection in Akita mice in which the DT receptor (DTR) was introduced genetically into the kidney tubule (AkitaSIX2-DTR). Mice were fed a high-fat diet (HFD). The expression ratio of p-ACC/ACC was determined at 3 days after DT and markers for tubular injury and DNA damage (g-H2AX) were evaluated at 3 days and 4 months. Cisplatin-injured HK2 cells were treated with an ACC inhibitor, PF-05175157 (ACCi) or a carnitine palmitoyltransferase 1 inhibitor, etomoxir (CPT1i) and examined for DNA damage and mitochondria fission.


P-ACC expression was increased and correlated with expression of tubular injury marker KIM-1 and myofibroblast marker a-SMA in human DN specimens. At day 3 after DT, ATI increased the p-ACC/ACC ratio in the Akita SIX2-DTR mice on HFD and resulted in enhanced expression of g-H2AX in KIM-1 positive tubules and kidney fibrosis at 4 months. When cisplatin-injured HK2 cells were treated with ACCi, which allowed b-oxidation of acyl-CoA, there was an increase in mitochondrial fission factor (MFF) without a further increase of g-H2AX. Etomoxir, which blocked acylcarnitine entry into mitochondria, reduced MFF and g-H2AX expression.


Increased levels of p-ACC were associated with increased tubular injury and fibrosis in human DN. P-ACC in injured renal epithelial cells permitted b-oxidation of acyl-CoA in damaged mitochondria and enhanced mitochondrial fission resulting in DNA damage plausibly from reactive oxygen species. Prevention of mitochondrial overload of acyl-CoA is a potential therapeutic target to mitigate mitochondria damage and DNA damage after ATI in DN.


  • NIDDK Support